5 results  1 of 1 

1 Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease
Hyejin Jang, Kyu Yeun Kim, Dong Soo Kim
Yonsei Med J.2018;59(1):113-118.   Published online 2017 November 29     DOI: http://dx.doi.org/10.3349/ymj.2018.59.1.113
      
2 Severe Skin Lesions or Arthritis May be Associated with Coronary Artery Lesions in Kawasaki Disease
Song Ee Youn, Hee Young Ju, Kyung Suk Lee, Sung Ho Cha, Mi Young Han, Kyung Lim Yoon
Pediatr Infect Vaccine.2016;23(2):102-108.   Published online 2016 August 25     DOI: http://dx.doi.org/10.14776/piv.2016.23.2.102
      
3 Kawasaki Disease: Laboratory Findings and an Immunopathogenesis on the Premise of a "Protein Homeostasis System"
Kyung-Yil Lee, Jung-Woo Rhim, Jin-Han Kang
Yonsei Med J.2012;53(2):262-275.   Published online 2012 January 30     DOI: http://dx.doi.org/10.3349/ymj.2012.53.2.262
      
4 Limitation of Prediction on Intravenous Immunoglobulin Responsiveness in Kawasaki Disease
Seong-Koo Kim, Ji-Yoon Han, Jung Woo Rhim, Jin Hee Oh, Ji-Whan Han, Kyung Yil Lee, Jin-Han Kang, Joon-Sung Lee
Korean J Pediatr Infect Dis.2010;17(2):169-176.   Published online 2010 December 31     DOI: http://dx.doi.org/10.14776/kjpid.2010.17.2.169
      
5 Characteristics of Kawasaki Disease Patients who are Unresponsive to High-dose Intravenous Immunoglobulin Therapy
Dong-Hyuk Kook, Yong-Min Ko, Keun-Young Lee, Dong-Un Kim, Kyung-Yil Lee, Joon-Sung Lee
Korean J Pediatr Infect Dis.2008;15(2):180-187.   Published online 2008 December 25     DOI: http://dx.doi.org/10.14776/kjpid.2008.15.2.180
      

 1 of 1